TNM-009

N/A

Report date: 2023/03/28 10:16:09

Base Information

Drug NameTNM-009
Drug Alias NameTNM-009TNM009
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionNerve growth factor inhibitors
TargetsNerve growth factor
Therapy Area/IndicationsCancer PainPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhuhai Trinomab Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesZhuhai Trinomab Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCancer PainPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A